The University of Chicago Header Logo

Justin Kline

Concepts (306)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Large B-Cell, Diffuse
8
2026
197
2.710
Why?
Programmed Cell Death 1 Receptor
8
2023
201
1.810
Why?
Leukemia, Myeloid, Acute
12
2021
850
1.400
Why?
Immunotherapy, Adoptive
9
2026
336
1.390
Why?
Hematopoietic Stem Cell Transplantation
17
2023
979
1.300
Why?
T-Lymphocytes
13
2026
1335
1.170
Why?
Immunotherapy
8
2023
831
1.070
Why?
Tumor Microenvironment
5
2025
621
0.990
Why?
T-Lymphocytes, Regulatory
4
2016
358
0.920
Why?
Hodgkin Disease
3
2021
144
0.920
Why?
Immune Tolerance
5
2017
388
0.900
Why?
Antibodies, Bispecific
1
2025
51
0.840
Why?
Antibodies, Monoclonal
7
2023
1422
0.820
Why?
Transplantation Conditioning
13
2020
389
0.810
Why?
B7-H1 Antigen
6
2020
333
0.780
Why?
Lymphoma
4
2020
255
0.770
Why?
Leukemia
5
2019
310
0.750
Why?
Melanoma, Experimental
3
2014
114
0.690
Why?
Tumor Escape
2
2020
56
0.670
Why?
Antigen-Presenting Cells
3
2017
147
0.660
Why?
Graft vs Host Disease
9
2020
382
0.650
Why?
Antineoplastic Agents
10
2023
2386
0.610
Why?
Cell Proliferation
5
2016
1801
0.580
Why?
Homeostasis
3
2012
474
0.570
Why?
Lymphoma, B-Cell
1
2020
110
0.570
Why?
Arabinonucleosides
3
2011
37
0.550
Why?
Neoplasms
8
2018
3382
0.540
Why?
Antineoplastic Combined Chemotherapy Protocols
8
2023
2666
0.510
Why?
Immune Evasion
1
2017
37
0.500
Why?
Antigens, CD19
4
2026
90
0.490
Why?
Transplantation, Homologous
16
2020
1029
0.470
Why?
CD8-Positive T-Lymphocytes
7
2025
701
0.470
Why?
Lymphocyte Activation
5
2019
825
0.470
Why?
Lymphoma, Non-Hodgkin
4
2013
262
0.450
Why?
Immunity, Innate
3
2016
482
0.440
Why?
Cell Differentiation
4
2025
1656
0.420
Why?
Signal Transduction
7
2026
3642
0.420
Why?
Animals
25
2026
29045
0.420
Why?
Hematologic Neoplasms
5
2023
384
0.420
Why?
Lymphocyte Depletion
4
2017
103
0.410
Why?
Humans
58
2026
98799
0.410
Why?
Interferon Type I
3
2026
170
0.400
Why?
Mice
18
2026
12762
0.400
Why?
Thymus Gland
1
2014
205
0.380
Why?
CD40 Antigens
1
2013
43
0.380
Why?
Geriatric Assessment
4
2020
193
0.370
Why?
Graft vs Tumor Effect
2
2010
26
0.350
Why?
Cross-Priming
1
2012
59
0.350
Why?
Proto-Oncogene Proteins c-bcl-2
2
2026
213
0.340
Why?
B7-1 Antigen
3
2016
75
0.340
Why?
Antigen Presentation
3
2020
234
0.330
Why?
Mice, Inbred C57BL
9
2016
3628
0.320
Why?
Hepatitis A Virus Cellular Receptor 2
2
2021
9
0.320
Why?
Cytotoxicity, Immunologic
2
2019
218
0.320
Why?
Adenine Nucleotides
2
2011
57
0.310
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2010
114
0.310
Why?
Cord Blood Stem Cell Transplantation
4
2017
91
0.310
Why?
Antibodies, Neoplasm
2
2009
87
0.300
Why?
Membrane Proteins
1
2016
1293
0.300
Why?
WT1 Proteins
1
2009
23
0.290
Why?
Salvage Therapy
1
2010
241
0.290
Why?
Antigens, Differentiation
1
2009
126
0.290
Why?
Rituximab
4
2023
138
0.280
Why?
Mice, Knockout
7
2016
2217
0.250
Why?
Membrane Glycoproteins
1
2009
446
0.250
Why?
Leukemia, T-Cell
1
2006
17
0.240
Why?
Antiviral Agents
2
2007
369
0.240
Why?
Transplantation, Autologous
5
2021
398
0.240
Why?
Flow Cytometry
4
2013
722
0.230
Why?
Ganciclovir
1
2006
35
0.230
Why?
Killer Cells, Natural
4
2021
298
0.230
Why?
Valine
1
2006
48
0.230
Why?
Acyclovir
1
2006
35
0.230
Why?
CD47 Antigen
2
2016
27
0.230
Why?
Peptides
1
2009
671
0.230
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2026
112
0.220
Why?
Cytomegalovirus Infections
1
2006
116
0.220
Why?
Bone Marrow Transplantation
1
2006
287
0.210
Why?
Cell- and Tissue-Based Therapy
2
2021
65
0.200
Why?
Survival Analysis
6
2017
1530
0.200
Why?
Sulfonamides
1
2026
352
0.200
Why?
Middle Aged
23
2019
29642
0.190
Why?
Aged
22
2020
21986
0.190
Why?
Calreticulin
2
2019
16
0.190
Why?
Lymphoma, Follicular
1
2023
74
0.190
Why?
Male
26
2025
47475
0.190
Why?
Receptors, Immunologic
1
2023
143
0.180
Why?
Neoplasm Recurrence, Local
6
2023
1538
0.180
Why?
Self Tolerance
2
2016
26
0.180
Why?
Cell Separation
2
2013
201
0.180
Why?
Antigens, Neoplasm
2
2016
366
0.180
Why?
Antibodies, Monoclonal, Murine-Derived
2
2013
79
0.170
Why?
Peripheral Blood Stem Cell Transplantation
2
2012
67
0.170
Why?
Histiocytes
1
2021
22
0.170
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2005
445
0.170
Why?
Receptors, Antigen, T-Cell
5
2026
454
0.170
Why?
Cell Line, Tumor
5
2016
2913
0.160
Why?
Disease Models, Animal
3
2016
2581
0.160
Why?
Jehovah's Witnesses
1
2021
21
0.160
Why?
Blood Component Removal
1
2020
29
0.160
Why?
Interferon-gamma
3
2013
478
0.160
Why?
Adult
18
2019
29698
0.160
Why?
Rhabdomyosarcoma, Alveolar
1
2019
5
0.150
Why?
Recurrence
4
2017
1274
0.150
Why?
Guidelines as Topic
1
2020
169
0.150
Why?
Female
24
2025
51997
0.150
Why?
Dendritic Cells
2
2016
547
0.150
Why?
Galectins
1
2019
15
0.150
Why?
Hydrazines
1
2019
36
0.150
Why?
Mitoxantrone
1
2019
65
0.150
Why?
Myelodysplastic Syndromes
2
2017
386
0.150
Why?
Fetal Blood
2
2017
95
0.150
Why?
Treatment Outcome
9
2026
9806
0.140
Why?
Clinical Trials as Topic
3
2010
1128
0.140
Why?
Gene Expression Regulation, Neoplastic
2
2020
1400
0.140
Why?
Interdisciplinary Communication
1
2019
137
0.140
Why?
Genomics
1
2025
914
0.140
Why?
Cytarabine
1
2019
218
0.140
Why?
Triazoles
1
2019
118
0.140
Why?
Proto-Oncogene Proteins c-myc
1
2019
160
0.130
Why?
Melphalan
2
2023
98
0.130
Why?
Clonal Anergy
2
2008
32
0.130
Why?
Receptors, Pattern Recognition
1
2017
20
0.130
Why?
Remission Induction
2
2017
764
0.130
Why?
Disease Management
1
2019
378
0.130
Why?
Preoperative Care
1
2019
420
0.130
Why?
Drug Therapy, Combination
2
2010
766
0.120
Why?
Gene Expression Regulation, Leukemic
2
2015
100
0.120
Why?
Health Services Misuse
1
2016
20
0.120
Why?
Patient Care Team
1
2019
318
0.120
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2017
150
0.120
Why?
Xanthones
1
2016
10
0.120
Why?
Haploidy
1
2016
30
0.120
Why?
Paramyxoviridae
1
2015
9
0.120
Why?
Multiple Myeloma
1
2020
372
0.120
Why?
Basic-Leucine Zipper Transcription Factors
1
2016
51
0.120
Why?
Genetic Engineering
1
2016
102
0.110
Why?
Community-Acquired Infections
1
2015
66
0.110
Why?
Mitogen-Activated Protein Kinase Kinases
1
2015
100
0.110
Why?
Lymphocyte Subsets
2
2013
71
0.110
Why?
fms-Like Tyrosine Kinase 3
1
2015
135
0.110
Why?
Immunologic Memory
1
2016
192
0.110
Why?
Immunity
1
2016
160
0.110
Why?
Respiratory Tract Infections
1
2015
112
0.110
Why?
Receptor, Interferon alpha-beta
1
2014
23
0.110
Why?
Adaptive Immunity
1
2016
194
0.110
Why?
Mice, Transgenic
3
2013
1608
0.100
Why?
Survival Rate
4
2014
2057
0.100
Why?
Enzyme-Linked Immunosorbent Assay
2
2013
374
0.100
Why?
Antigens, CD34
4
2017
162
0.100
Why?
Antibodies, Monoclonal, Humanized
3
2011
1105
0.100
Why?
Gene Expression Regulation
2
2017
2023
0.100
Why?
Hematopoietic Stem Cell Mobilization
2
2012
52
0.100
Why?
Toll-Like Receptor 9
1
2013
25
0.100
Why?
Haplotypes
2
2013
657
0.100
Why?
Interferon-beta
1
2014
127
0.100
Why?
Interleukin-18
1
2013
27
0.100
Why?
STAT3 Transcription Factor
1
2013
91
0.100
Why?
Glucocorticoids
1
2015
371
0.100
Why?
Inflammation
1
2020
1134
0.100
Why?
Alemtuzumab
3
2011
91
0.100
Why?
Lymphoma, T-Cell, Peripheral
1
2013
34
0.100
Why?
Transplantation, Haploidentical
3
2017
29
0.100
Why?
Biological Products
2
2026
191
0.100
Why?
Epothilones
1
2013
13
0.100
Why?
Molecular Targeted Therapy
1
2015
331
0.090
Why?
Repressor Proteins
1
2016
450
0.090
Why?
Young Adult
7
2017
7598
0.090
Why?
Angiogenesis Inhibitors
1
2014
281
0.090
Why?
Intensive Care Units
1
2016
476
0.090
Why?
Neovascularization, Pathologic
1
2014
356
0.090
Why?
Prostate
1
2016
434
0.090
Why?
Tumor Cells, Cultured
2
2015
1029
0.090
Why?
Combined Modality Therapy
3
2010
1754
0.090
Why?
Translocation, Genetic
2
2019
246
0.090
Why?
Hematopoiesis
1
2013
187
0.090
Why?
Drug Resistance, Neoplasm
2
2019
671
0.090
Why?
Cell Movement
2
2016
821
0.080
Why?
Tissue Donors
2
2012
581
0.080
Why?
Protein Kinase Inhibitors
1
2015
642
0.080
Why?
Graft Survival
2
2013
999
0.080
Why?
Leukocyte Transfusion
1
2010
15
0.080
Why?
Aged, 80 and over
6
2019
7461
0.080
Why?
Cell Survival
1
2013
1018
0.080
Why?
Hospitalization
1
2016
993
0.080
Why?
Prognosis
5
2023
4139
0.080
Why?
Immunomodulation
1
2010
65
0.080
Why?
Incidence
3
2015
1798
0.080
Why?
Apoptosis Regulatory Proteins
1
2010
201
0.080
Why?
Interleukin-2
1
2010
246
0.070
Why?
Graft Rejection
1
2016
1189
0.070
Why?
Antigens, CD
1
2010
482
0.070
Why?
Stem Cell Transplantation
2
2020
196
0.070
Why?
Neoplasm Transplantation
1
2009
400
0.070
Why?
Chimerism
2
2020
38
0.070
Why?
Cells, Cultured
1
2013
2859
0.070
Why?
Immunosuppressive Agents
2
2015
1021
0.070
Why?
Neoplasm Staging
2
2010
2087
0.070
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2009
177
0.070
Why?
Down-Regulation
1
2009
529
0.060
Why?
Acute Kidney Injury
1
2011
361
0.060
Why?
Immunity, Cellular
1
2007
187
0.060
Why?
Melanoma
1
2011
523
0.060
Why?
Cyclosporine
1
2007
241
0.060
Why?
Lymphopenia
1
2006
31
0.060
Why?
Models, Animal
1
2007
282
0.060
Why?
Time Factors
2
2013
5586
0.060
Why?
Autoimmune Diseases
1
2007
262
0.060
Why?
Protein Binding
1
2009
1564
0.060
Why?
Neoplasms, Experimental
1
2006
263
0.050
Why?
Disease Progression
1
2009
1621
0.050
Why?
Age Factors
3
2015
1976
0.050
Why?
Mutation
1
2015
4443
0.050
Why?
Pilot Projects
2
2020
978
0.050
Why?
Apoptosis
2
2026
1754
0.050
Why?
RNA, Small Interfering
2
2015
573
0.050
Why?
Vidarabine
1
2023
107
0.050
Why?
Fluorodeoxyglucose F18
1
2023
146
0.050
Why?
Histocompatibility Testing
2
2017
145
0.050
Why?
Tumor Burden
1
2023
330
0.040
Why?
Adolescent
3
2016
10168
0.040
Why?
Risk Factors
3
2018
6295
0.040
Why?
Illinois
2
2012
531
0.040
Why?
Health Planning Guidelines
1
2019
25
0.040
Why?
Gene Expression Profiling
1
2006
1572
0.040
Why?
T-Lymphocytes, Cytotoxic
1
2021
322
0.040
Why?
Health Plan Implementation
1
2019
62
0.040
Why?
Standard of Care
1
2019
71
0.040
Why?
Interleukin-15
1
2019
78
0.040
Why?
Vincristine
1
2019
102
0.040
Why?
Disease-Free Survival
2
2012
1196
0.040
Why?
Treatment Failure
1
2019
300
0.030
Why?
Etoposide
1
2019
207
0.030
Why?
Maintenance Chemotherapy
1
2019
96
0.030
Why?
Prednisone
1
2019
252
0.030
Why?
Prospective Studies
2
2020
4837
0.030
Why?
Cyclophosphamide
1
2019
285
0.030
Why?
Preoperative Period
1
2018
103
0.030
Why?
Bone Marrow Cells
1
2019
269
0.030
Why?
Maximum Tolerated Dose
1
2019
265
0.030
Why?
Doxorubicin
1
2019
285
0.030
Why?
Premedication
1
2017
57
0.030
Why?
Unrelated Donors
1
2017
50
0.030
Why?
Drug Administration Schedule
1
2019
837
0.030
Why?
T-Lymphocyte Subsets
1
2019
291
0.030
Why?
Retrospective Studies
2
2023
11104
0.030
Why?
Cause of Death
1
2018
279
0.030
Why?
Palliative Care
1
2019
291
0.030
Why?
Clinical Decision-Making
1
2019
306
0.030
Why?
Feasibility Studies
1
2019
818
0.030
Why?
Receptors, CCR7
1
2016
20
0.030
Why?
B7-2 Antigen
1
2016
42
0.030
Why?
CD8 Antigens
1
2016
82
0.030
Why?
Kaplan-Meier Estimate
1
2018
909
0.030
Why?
Histocompatibility
1
2016
71
0.030
Why?
U937 Cells
1
2015
32
0.030
Why?
Multiplex Polymerase Chain Reaction
1
2015
38
0.030
Why?
Patient Selection
1
2019
725
0.030
Why?
Terminal Care
1
2016
147
0.030
Why?
Comorbidity
1
2018
1037
0.030
Why?
Prevalence
1
2018
1396
0.030
Why?
Transplant Recipients
1
2015
182
0.030
Why?
Xenograft Model Antitumor Assays
1
2015
559
0.020
Why?
Bortezomib
1
2013
83
0.020
Why?
Boronic Acids
1
2013
56
0.020
Why?
Immunoglobulin Isotypes
1
2013
33
0.020
Why?
Mice, Inbred NOD
1
2013
228
0.020
Why?
Pneumococcal Vaccines
1
2013
32
0.020
Why?
Mice, SCID
1
2013
278
0.020
Why?
Gene Silencing
1
2013
178
0.020
Why?
CpG Islands
1
2013
177
0.020
Why?
Mice, Inbred BALB C
1
2015
1113
0.020
Why?
Lymphocyte Count
1
2013
99
0.020
Why?
Pyrazines
1
2013
98
0.020
Why?
Deoxycytidine
1
2013
218
0.020
Why?
Virus Diseases
1
2013
83
0.020
Why?
Adult Stem Cells
1
2011
31
0.020
Why?
STAT1 Transcription Factor
1
2011
60
0.020
Why?
L-Lactate Dehydrogenase
1
2010
71
0.020
Why?
Glomerular Filtration Rate
1
2011
304
0.020
Why?
Family
1
2012
330
0.020
Why?
Risk
1
2011
662
0.020
Why?
Lymphatic Metastasis
1
2011
519
0.020
Why?
B-Lymphocytes
1
2014
737
0.020
Why?
DNA
1
2015
1274
0.020
Why?
Predictive Value of Tests
1
2014
1792
0.020
Why?
Transcription Factors
1
2016
1724
0.020
Why?
Lymph Nodes
1
2011
563
0.020
Why?
Cohort Studies
1
2014
3242
0.020
Why?
Genes, RAG-1
1
2006
11
0.020
Why?
Adoptive Transfer
1
2006
174
0.010
Why?
Lewis X Antigen
1
2006
9
0.010
Why?
Myeloid Progenitor Cells
1
2006
16
0.010
Why?
Expressed Sequence Tags
1
2006
34
0.010
Why?
Chromosomes, Human, Pair 11
1
2006
106
0.010
Why?
Chromosomes, Human, Pair 9
1
2006
81
0.010
Why?
Gene Library
1
2006
126
0.010
Why?
DNA, Complementary
1
2006
380
0.010
Why?
Leukocytes, Mononuclear
1
2006
213
0.010
Why?
Cost of Illness
1
2005
165
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2006
700
0.010
Why?
Cytokines
1
2006
890
0.010
Why?
Neoplasm Metastasis
1
2006
1102
0.010
Why?
Computational Biology
1
2006
620
0.010
Why?
RNA
1
2006
596
0.010
Why?
RNA, Messenger
1
2006
2076
0.010
Why?
Kline's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (306)
Explore
_
Co-Authors (48)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_